GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » Cash And Cash Equivalents

MeVis Medical Solutions AG (XTER:M3V) Cash And Cash Equivalents : €4.87 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG Cash And Cash Equivalents?

MeVis Medical Solutions AG's quarterly cash and cash equivalents increased from Mar. 2023 (€4.42 Mil) to Sep. 2023 (€7.74 Mil) but then stayed the same from Sep. 2023 (€7.74 Mil) to Mar. 2024 (€4.87 Mil).

MeVis Medical Solutions AG's annual cash and cash equivalents increased from Sep. 2021 (€7.62 Mil) to Sep. 2022 (€9.32 Mil) but then declined from Sep. 2022 (€9.32 Mil) to Sep. 2023 (€7.74 Mil).


MeVis Medical Solutions AG Cash And Cash Equivalents Historical Data

The historical data trend for MeVis Medical Solutions AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG Cash And Cash Equivalents Chart

MeVis Medical Solutions AG Annual Data
Trend Dec13 Dec14 Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.60 3.95 7.62 9.32 7.74

MeVis Medical Solutions AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.31 9.32 4.42 7.74 4.87

MeVis Medical Solutions AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


MeVis Medical Solutions AG  (XTER:M3V) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


MeVis Medical Solutions AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


MeVis Medical Solutions AG (XTER:M3V) Business Description

Traded in Other Exchanges
Address
Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines